The Outcome of COVID-19 in Patients with a History of Taking Rituximab: A Narrative Review

Coronavirus disease 2019 (COVID-19) is a recently emerging disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Notably, the safety of immunosuppressive medications is a major concern during an infectious disease pandemic. Rituximab (RTX), as a monoclonal antibody against...

Descripción completa

Detalles Bibliográficos
Autores principales: Yarahmadi, Pourya, Alirezaei, Mohammad, Forouzannia, Seyed Mohammad, Naser Moghadasi, Abdorreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shiraz University of Medical Sciences 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611224/
https://www.ncbi.nlm.nih.gov/pubmed/34840381
http://dx.doi.org/10.30476/IJMS.2021.88717.1946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611224/
https://www.ncbi.nlm.nih.gov/pubmed/34840381
http://dx.doi.org/10.30476/IJMS.2021.88717.1946

Ejemplares similares